Heart health: Wegovy may lower cardiovascular risks
Researchers report that people who are overweight or have obesity improved their cardiovascular risk factors after taking the weight-loss drug Wegovy for one year
Source: medicalnewstoday.com
Page 8 - Obesity Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Obesity Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Obesity Program Today - Breaking & Trending Today
Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows
New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.
Source: news-medical.net
Study shows Wegovy effective for weight loss
It's a social media darling and one of the hottest prescription medications on the U.S. market. But does Wegovy really help patients lose weight? Yes, a new study suggests.
Source: upi.com
Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss
New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.
Source: news-medical.net
Revamping Weight Loss Solutions Using Anti-Obesity Medication
Recently FDA-approved drug semaglutide has proven as a highly effective anti-obesity medication showcasing remarkable weight loss benefits.
Source: medindia.net